\
&
Contact us
\
&
Contact us
This was 11 months ago
Locationonline
ProgrammesTune in on Wednesday 6 November 2024 for a half-day online Info Day dedicated to the European Innovation Council (EIC) Accelerator Challenges under the EIC Work Programme 2025.
Representatives of the European Commission - from the European Innovation Council and SMEs Executive Agency (EISMEA) and few Directorates-General (DG RTD - Research and Innovation, DG CNECT - for Communications Networks, Content and Technology, DG DEFIS - Defence Industry and Space and DG MOVE - Mobility and Transport) - will present the new Challenges for 2025 under the EIC Accelerator scheme and reply to the questions received from participants.
There is no need for registrations as the event will be web streamed live.
More information and the link to the live stream can be found here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
